DIL
TNYA icon

Deeter Investments LLP’s Tenaya Therapeutics TNYA Stock Holding History

Deeter Investments LLP’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$53.4K Buy
+75,000
New +$102K 0.01% 107

Other funds holding TNYA

CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Deeter Investments LLP's TNYA Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Tenaya Therapeutics (TNYA) in Q4 2025: 75,000 shares worth $53.4K. The stake represents 0.01% of the portfolio and ranks #107 among its holdings.

98 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • Deeter Investments LLP held 75,000 shares of Tenaya Therapeutics worth $53.4K as of Q4 2025.
  • Tenaya Therapeutics was a new Deeter Investments LLP position in Q4 2025.
  • Tenaya Therapeutics made up 0.01% of Deeter Investments LLP's portfolio in Q4 2025, its #107 holding.
  • 98 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.